Cargando…
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
INTRODUCTION: To depict the genomic landscape of Chinese early-stage lung squamous cell carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 expression, and immune infiltrates. METHODS: Whole-exome sequencing was performed on 189 surgically resected LUSC. TMB was...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625041/ https://www.ncbi.nlm.nih.gov/pubmed/31299995 http://dx.doi.org/10.1186/s13045-019-0762-1 |
_version_ | 1783434336568082432 |
---|---|
author | Jiang, Tao Shi, Jinpeng Dong, Zhengwei Hou, Likun Zhao, Chao Li, Xuefei Mao, Beibei Zhu, Wei Guo, Xianchao Zhang, Henghui He, Ji Chen, Xiaoxia Su, Chunxia Ren, Shengxiang Wu, Chunyan Zhou, Caicun |
author_facet | Jiang, Tao Shi, Jinpeng Dong, Zhengwei Hou, Likun Zhao, Chao Li, Xuefei Mao, Beibei Zhu, Wei Guo, Xianchao Zhang, Henghui He, Ji Chen, Xiaoxia Su, Chunxia Ren, Shengxiang Wu, Chunyan Zhou, Caicun |
author_sort | Jiang, Tao |
collection | PubMed |
description | INTRODUCTION: To depict the genomic landscape of Chinese early-stage lung squamous cell carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 expression, and immune infiltrates. METHODS: Whole-exome sequencing was performed on 189 surgically resected LUSC. TMB was defined as the sum of nonsynonymous single nucleotide and indel variants. CD8(+) tumor-infiltrating lymphocyte (TIL) density and PD-L1 expression were evaluated by immunohistochemistry. Six immune infiltrates were estimated using an online database. RESULTS: The median TMB was 9.43 mutations per megabase. Positive PD-L1 expression and CD8(+) TILs density were identified in 24.3% and 78.8%. PIK3CA amplification was associated with significantly higher TMB (P = 0.036). Frequent genetic alterations had no impact on PD-L1 expression but PIK3CA amplification and KEAP1 mutation were independently associated with significantly lower CD8(+) TIL density (P < 0.001, P = 0.005, respectively). Low TMB and high CD8(+) TIL density were independently associated with longer disease-free survival (DFS) while none of them could individually predict the overall survival (OS). Combination of TMB and PD-L1 expression or TMB and CD8(+) TIL density could stratify total populations into two groups with distinct prognosis. Classifying tumor-immune microenvironment based on PD-L1 expression and CD8(+) TIL density showed discrepant genomic alterations but similar TMB, clinical features, and OS. Notably, patients with different smoking status had distinct prognostic factors. CONCLUSION: The combination of TMB, PD-L1 expression, immune infiltrates, and smoking status showed the feasibility to subgroup stratification in Chinese patients with early-stage LUSC, which might be helpful for future design of personalized immunotherapy trials in LUSC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-019-0762-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6625041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66250412019-07-23 Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma Jiang, Tao Shi, Jinpeng Dong, Zhengwei Hou, Likun Zhao, Chao Li, Xuefei Mao, Beibei Zhu, Wei Guo, Xianchao Zhang, Henghui He, Ji Chen, Xiaoxia Su, Chunxia Ren, Shengxiang Wu, Chunyan Zhou, Caicun J Hematol Oncol Research INTRODUCTION: To depict the genomic landscape of Chinese early-stage lung squamous cell carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 expression, and immune infiltrates. METHODS: Whole-exome sequencing was performed on 189 surgically resected LUSC. TMB was defined as the sum of nonsynonymous single nucleotide and indel variants. CD8(+) tumor-infiltrating lymphocyte (TIL) density and PD-L1 expression were evaluated by immunohistochemistry. Six immune infiltrates were estimated using an online database. RESULTS: The median TMB was 9.43 mutations per megabase. Positive PD-L1 expression and CD8(+) TILs density were identified in 24.3% and 78.8%. PIK3CA amplification was associated with significantly higher TMB (P = 0.036). Frequent genetic alterations had no impact on PD-L1 expression but PIK3CA amplification and KEAP1 mutation were independently associated with significantly lower CD8(+) TIL density (P < 0.001, P = 0.005, respectively). Low TMB and high CD8(+) TIL density were independently associated with longer disease-free survival (DFS) while none of them could individually predict the overall survival (OS). Combination of TMB and PD-L1 expression or TMB and CD8(+) TIL density could stratify total populations into two groups with distinct prognosis. Classifying tumor-immune microenvironment based on PD-L1 expression and CD8(+) TIL density showed discrepant genomic alterations but similar TMB, clinical features, and OS. Notably, patients with different smoking status had distinct prognostic factors. CONCLUSION: The combination of TMB, PD-L1 expression, immune infiltrates, and smoking status showed the feasibility to subgroup stratification in Chinese patients with early-stage LUSC, which might be helpful for future design of personalized immunotherapy trials in LUSC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-019-0762-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-12 /pmc/articles/PMC6625041/ /pubmed/31299995 http://dx.doi.org/10.1186/s13045-019-0762-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Jiang, Tao Shi, Jinpeng Dong, Zhengwei Hou, Likun Zhao, Chao Li, Xuefei Mao, Beibei Zhu, Wei Guo, Xianchao Zhang, Henghui He, Ji Chen, Xiaoxia Su, Chunxia Ren, Shengxiang Wu, Chunyan Zhou, Caicun Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma |
title | Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma |
title_full | Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma |
title_fullStr | Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma |
title_full_unstemmed | Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma |
title_short | Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma |
title_sort | genomic landscape and its correlations with tumor mutational burden, pd-l1 expression, and immune cells infiltration in chinese lung squamous cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625041/ https://www.ncbi.nlm.nih.gov/pubmed/31299995 http://dx.doi.org/10.1186/s13045-019-0762-1 |
work_keys_str_mv | AT jiangtao genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT shijinpeng genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT dongzhengwei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT houlikun genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT zhaochao genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT lixuefei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT maobeibei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT zhuwei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT guoxianchao genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT zhanghenghui genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT heji genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT chenxiaoxia genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT suchunxia genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT renshengxiang genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT wuchunyan genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma AT zhoucaicun genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma |